Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation (Q79116877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

17 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

17 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

17 March 2024

4

Bruce R Blazar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

3

Patricia A Taylor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Wayne R. Godfrey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525783

17 March 2024

Mark R. Krampf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525783

17 March 2024

Patricia A. Taylor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525783

17 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14525783

17 March 2024

publication date

2 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

http://ashpublications.org/blood/article-pdf/103/3/1158/1694930/zh800304001158.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

17 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1158-1165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

Transplants across human leukocyte antigen barriers.

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Recent advances in graft-versus-host disease (GVHD) prevention

17 March 2024

3

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

17 March 2024

4

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantation

17 March 2024

5

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

17 March 2024

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions

17 March 2024

9

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations

17 March 2024

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis

17 March 2024

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease

17 March 2024

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69).

17 March 2024

14

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death

17 March 2024

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process

17 March 2024

17

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences

17 March 2024

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment

17 March 2024

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study

17 March 2024

21

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

17 March 2024

22

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question

17 March 2024

23

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

17 March 2024

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

17 March 2024

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

17 March 2024

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use.

17 March 2024

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

17 March 2024

28

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Regulation of Toll-like receptors in human monocytes and dendritic cells

17 March 2024

29

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Design of limiting dilution analysis experiments for helper T lymphocyte precursor frequency determination in the context of allogeneic bone marrow transplantation

17 March 2024

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses

17 March 2024

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

CIITA activates the expression of MHC class II genes in mouse T cells

17 March 2024

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes

17 March 2024

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Immunobiology of dendritic cells

17 March 2024

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses

17 March 2024

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

The central role of CD4(+) T cells in the antitumor immune response

17 March 2024

36

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

17 March 2024

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

17 March 2024

38

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-04-1098

17 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14525783%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference